Organon & Co.
OGN
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzysā¦ read more
Healthcare
Drug ManufacturersāGeneral
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$7.31
Price+1.74%
$0.13
1Y
Price
Market Cap
$1.899b
Small
Price/Earnings 3y Avg5y Avg
3.8x
Premium
Premium
Financials Overview
Key metrics over the past few years+28.7%
EBITDA Margin+10.0%
Net Profit Margin+9.3%
Free Cash Flow MarginRevenue
$6.301b
-1.6%
1y CAGR+0.7%
3y CAGR+0.0%
5y CAGREarnings
$501m
-42.0%
1y CAGR-15.3%
3y CAGR-19.5%
5y CAGREPS
$1.92
-42.3%
1y CAGR-15.9%
3y CAGR-20.1%
5y CAGRBook Value
$906m
$13.552b
Assets$12.646b
Liabilities$8.828b
DebtDebt to Assets
65.1%
5.6x
Debt to EBITDAFree Cash Flow
$566m
-3.7%
1y CAGR+10.1%
3y CAGR-11.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company